Take advantage of partnership opportunities

To complement internal research and development, Purdue Pharma Canada is seeking in-licensing opportunities of prescription and over-the-counter (OTC) products for Canada.

As a market leader in the treatment of pain, expanding our portfolio of analgesics is a key objective.

Therapeutic areas that are of interest include:

• Analgesia
• Gastroenterology
• Neurology
• Oncology
• Over-the-Counter Medications
• Palliative Care (comfort-care in the last stage of a terminal illness)
• Urology

Preference is for products that are in late-stage clinical development with the completion of Phase II studies.

For further information please contact:

Mr. Danny Chen
Director, Business Development
Purdue Pharma Canada
575 Granite Court
Pickering, Ontario
Canada L1W 3W8

T: 905-420-4994
F: 905-420-6011
danny.chen@purdue.ca